Showing results (201-210 of 213) with videos related to
Sort By:
Pageof 22
Breast Cancer (Tokyo, Japan)|August 12, 2020
Fibromatosis of the breast: a 10-year multi-institutional experience and review of the literatureMichael R Boland, Timothy Nugent, Jack Nolan, et al.The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|April 21, 2026
Total thyroidectomy or hemithyroidectomy for differentiated thyroid carcinoma?Jennifer L McGarry, Alexandra Zaborowski, Nicola McShane, et al.European Journal of Human Genetics : EJHG|January 17, 2013
Rare missense neuronal cadherin gene (CDH2) variants in specific obsessive-compulsive disorder and Tourette disorder phenotypesPablo R Moya, Nicholas H Dodman, Kiara R Timpano, et al.Molecular Neurobiology|May 25, 2019
Understanding the Scientific Basis of Post-traumatic Stress Disorder (PTSD): Precision Behavioral Management Overrides StigmatizationKenneth Blum, M C Gondré-Lewis, E J Modestino, et al.Journal of Systems and Integrative Neuroscience|February 22, 2021
Biotechnical development of genetic addiction risk score (GARS) and selective evidence for inclusion of polymorphic allelic risk in substance use disorder (SUD)K Blum, A Bowirrat, D Baron, et al.Current Oncology (Toronto, Ont.)|March 27, 2024
Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in IrelandLynda M McSorley, Mehala Tharmabala, Fathiya Al Rahbi, et al.Breast Cancer Research and Treatment|April 9, 2021
Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in IrelandL M McSorley, M Tharmabala, F Al Rahbi, et al.The British Journal of Surgery|December 6, 2023
Nodal positivity in patients with clinically and radiologically node-negative breast cancer treated with neoadjuvant chemotherapy: multicentre collaborative studyAlexandra M Zaborowski, Katie Doogan, Siobhan Clifford, et al.Surgical Oncology|January 22, 2026
The rate of non-sentinel lymph node metastases at axillary dissection in patients with a positive sentinel lymph node after neoadjuvant chemotherapyA M Zaborowski, F Wehrmann, J McGarry, et al.Breast Cancer Research and Treatment|October 4, 2024
Irish national real-world analysis of the clinical and economic impact of 21-gene oncotype DX® testing in early-stage, 1-3 lymph node-positive, oestrogen receptor-positive, HER2-negative, breast cancerI M Browne, R A McLaughlin, C S Weadick, et al.Pageof 22